Bank of New York Mellon’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Buy |
89,883
+5,842
| +7% | +$119K | ﹤0.01% | 2784 |
|
|
2025
Q1 | $1.68M | Sell |
84,041
-418
| -0.5% | -$8.37K | ﹤0.01% | 2765 |
|
|
2024
Q4 | $2.25M | Buy |
84,459
+7,881
| +10% | +$210K | ﹤0.01% | 2699 |
|
|
2024
Q3 | $2.18M | Sell |
76,578
-20,110
| -21% | -$574K | ﹤0.01% | 2702 |
|
|
2024
Q2 | $2.1M | Buy |
96,688
+12,583
| +15% | +$274K | ﹤0.01% | 2765 |
|
|
2024
Q1 | $1.86M | Sell |
84,105
-9,203
| -10% | -$204K | ﹤0.01% | 2796 |
|
|
2023
Q4 | $2.01M | Buy |
93,308
+12,167
| +15% | +$263K | ﹤0.01% | 2830 |
|
|
2023
Q3 | $1.37M | Buy |
81,141
+1,058
| +1% | +$17.9K | ﹤0.01% | 3003 |
|
|
2023
Q2 | $1.1M | Sell |
80,083
-1,285
| -2% | -$17.6K | ﹤0.01% | 3140 |
|
|
2023
Q1 | $1.85M | Sell |
81,368
-1,614
| -2% | -$36.7K | ﹤0.01% | 2848 |
|
|
2022
Q4 | $1.95M | Buy |
82,982
+1,964
| +2% | +$46.2K | ﹤0.01% | 2861 |
|
|
2022
Q3 | $2.11M | Buy |
81,018
+9,780
| +14% | +$255K | ﹤0.01% | 2808 |
|
|
2022
Q2 | $1.56M | Sell |
71,238
-30,648
| -30% | -$672K | ﹤0.01% | 2968 |
|
|
2022
Q1 | $4.57M | Buy |
101,886
+14,658
| +17% | +$657K | ﹤0.01% | 2473 |
|
|
2021
Q4 | $3.74M | Sell |
87,228
-1,270
| -1% | -$54.4K | ﹤0.01% | 2616 |
|
|
2021
Q3 | $5.89M | Buy |
88,498
+7,143
| +9% | +$475K | ﹤0.01% | 2402 |
|
|
2021
Q2 | $5.97M | Buy |
81,355
+3,342
| +4% | +$245K | ﹤0.01% | 2396 |
|
|
2021
Q1 | $5.34M | Sell |
78,013
-7,325
| -9% | -$501K | ﹤0.01% | 2420 |
|
|
2020
Q4 | $5.73M | Sell |
85,338
-6,736
| -7% | -$452K | ﹤0.01% | 2298 |
|
|
2020
Q3 | $4.74M | Buy |
92,074
+36,300
| +65% | +$1.87M | ﹤0.01% | 2249 |
|
|
2020
Q2 | $2.1M | Buy |
55,774
+8,205
| +17% | +$309K | ﹤0.01% | 2649 |
|
|
2020
Q1 | $1.42M | Buy |
47,569
+21,383
| +82% | +$637K | ﹤0.01% | 2733 |
|
|
2019
Q4 | $900K | Buy |
+26,186
| New | +$900K | ﹤0.01% | 3297 |
|